Complete sequence determination of the mouse and human CTLA4 gene loci: Cross-species DNA sequence similarity beyond exon borders

Genomics

Volumn 60, Issue 3, 1999, Pages 341-355

  Ling, Vincent ^a   Wu, Paul W ^a   Finnerty, Heather F ^a   Sharpe, Arlene H ^b   Gray, Gary S ^a   Collins, Mary ^a  

^a PFIZER INC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; T LYMPHOCYTE RECEPTOR;

ARTICLE; DNA SEQUENCE; EXON; GENE LOCUS; GENE STRUCTURE; HUMAN; LYMPHOID TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

RODENTIA;

EID: 0033568670     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1999.5930     Document Type: Article

References (42)

1. Ansari-Lari M. A., Oeltjen J. C., Schwartz S., Zhang Z., Muzny D. M., Lu J., Gorrell J. H., Chinault A. C., Belmont J. W., Miller W., Gibbs R. A. Comparative sequence analysis of a gene-rich cluster at human chromosome 12p13 and its syntenic region in mouse chromosome 6. Genome Res. 8:1998;29-40.
2. Balzano C., Buonavista N., Rouvier E., Golstein P. CTLA-4 and CD28: Similar proteins, neighbouring genes. Int. J. Cancer Suppl. 7:1992;28-32.
3. Bluestone J. A. Is CTLA-4 a master switch for peripheral T cell tolerance? J. Immunol. 158:1997;1989-1993.
4. Braun J., Donner H., Siegmund T., Walfish P. G., Usadel K. H., Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens. 51:1998;563-566.
5. Brunet J. F., Denizot F., Luciani M. F., Roux-Dosseto M., Suzan M., Mattei M. G., Golstein P. A new member of the immunoglobulin superfamily - CTLA-4. Nature. 328:1987;267-270.
6. Calvo C. R., Amsen D., Kruisbeek A. M. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J. Exp. Med. 186:1997;1645-1653.
7. Chuang E., Alegre M. L., Duckett C. S., Noel P. J., Vander Heiden M. G., Thompson C. B. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 159:1997;144-151.
8. Colucci F. C., Bergman M-L., Penha-Goncalves C., Cilio C. M., Holmberg D. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibilty region. Proc. Natl. Acad. Sci. USA. 94:1997;8670-8674.
9. Dariavach P., Mattei M. G., Golstein P., Lefranc M. P. Human Ig superfamily CTLA-4 gene: Chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur. J. Immunol. 18:1988;1901-1905.
10. Donner H., Braun J., Seidl C., Rau H., Finke R., Ventz M., Walfish P. G., Usadel K. H., Badenhoop K. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J. Clin. Endocrinol. Metab. 82:1997a;4130-4132.
11. Donner H., Rau H., Walfish P. G., Braun J., Siegmund T., Finke R., Herwig J., Usadel K. H., Badenhoop K. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 82:1997b;143-146.
12. Epplen C., Santos E. J., Maueler W., van Helden P., Epplen J. T. On simple repetitive DNA sequences and complex diseases. Electrophoresis. 18:1997;1577-1585.
13. Epplen J. T., Maueler W., Epplen C. Exploiting the informativity of 'meaningless' simple repetitive DNA from indirect gene diagnosis to multilocus genome scanning. Biol. Chem. Hoppe Seyler. 375:1994;795-801.
14. Finn P. W., He H., Wang Y., Wang Z., Guan G., Listman J., Perkins D. L. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability. J. Immunol. 158:1997;4074-4081.
15. Hardison R. C., Oeltjen J., Miller W. Long human-mouse sequence alignments reveal novel regulatory elements: A reason to sequence the mouse genome. Genome Res. 7:1997;959-966.
16. Harper K., Balzano C., Rouvier E., Mattei M. G., Luciani M. F., Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147:1991;1037-1044.
17. Huang D., Liu L., Noren K., Xia S. Q., Trifunovic J., Pirskanen R., Lefvert A. K. Genetic association of Ctla-4 to myasthenia gravis with thymoma. J. Neuroimmunol. 88:1998;192-198.
18. June C. H., Bluestone J. A., Nadler L. M., Thompson C. B. The B7 and CD28 receptor families. Immunol. Today. 15:1994;321-331.
19. Koop B. F., Hood L. Striking sequence similarity over almost 100 kilobases of human and mouse T-cell receptor DNA. Nat. Genet. 7:1994;48-53.
20. Koop B. F., Richards J. E., Durfee T. D., Bansberg J., Wells J., Gilliam A. C., Chen H. L., Clausell A., Tucker P. W., Blattner F. R. Analysis and comparison of the mouse and human immunoglobulin heavy chain JH-Cmu-Cdelta locus. Mol. Phylogenet. Evol. 5:1996;33-49.
21. Kotsa K., Watson P. F., Weetman A. P. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin. Endocrinol. 46:1997;551-554.
22. Ling V., Munroe R. C., Murphy E. A., Gray G. S. Embryonic stem cells and embryoid bodies express lymphocyte costimulatory molecules. Exp. Cell Res. 241:1998;55-65.
23. Liu Y. Is CTLA-4 a negative regulator for T-cell activation? Immunol. Today. 18:1997;569-572.
24. Makalowski W., Boguski M. S. Evolutionary parameters of the transcribed mammalian genome: An analysis of 2820 orthologous rodent and human sequences. Proc. Natl. Acad. Sci. USA. 95:1998;9407-9412.
25. Marengere L. E., Waterhouse P., Duncan G. S., Mittrucker H. W., Feng G. S., Mak T. W. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science. 272:1996;1170-1173.
26. Marron M. P., Raffel L. J., Garchon H. J., Jacob C. O., Serrano-Rios M., Martinez Larrad M. T., Teng W. P., Park Y., Zhang Z. X., Goldstein D. R., Tao Y. W., Beaurain G., Bach J. F., Huang H. S., Luo D. F., Zeidler A., Rotter J. I., Yang M. C., Modilevsky T., Maclaren N. K., She J. X. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum. Mol. Genet. 6:1997;1275-1282.
27. Nistico L., Buzzetti R., Pritchard L. E., Van der Auwera B., Giovannini C., Bosi E., Larrad M. T., Rios M. S., Chow C. C., Cockram C. S., Jacobs K., Mijovic C., Bain S. C., Barnett A. H., Vandewalle C. L., Schuit F., Gorus F. K., Tosi R., Pozzilli P., Todd J. A. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 5:1996;1075-1080.
28. Oeltjen J. C., Malley T. M., Muzny D. M., Miller W., Gibbs R. A., Belmont J. W. Large-scale comparative sequence analysis of the human and murine Bruton's tyrosine kinase loci reveals conserved regulatory domains. Genome Res. 7:1997;315-329.
29. Parsons K. R., Young J. R., Collins B. A., Howard C. J. Cattle CTLA-4, CD28 and chicken CD28 bind CD86: MYPPPY is not conserved in cattle CD28. Immunogenetics. 43:1996;388-391.
30. Perkins D., Wang Z., Donovan C., He H., Mark D., Guan G., Wang Y., Walunas T., Bluestone J., Listman J. Regulation of CTLA-4 expression during T cell activation. J. Immunol. 156:1996;4154-4159.
31. Phinney D. G., Tseng S. W., Hall B., Ryder K. Chromosomal integration dependent induction of junB by growth factors requires multiple flanking evolutionarily conserved sequences. Oncogene. 13:1996;1875-1883.
32. Phinney D. G., Tseng S. W., Ryder K. Complex genetic organization of junB: Multiple blocks of flanking evolutionarily conserved sequence at the murine and human junB loci. Genomics. 28:1995;228-234.
33. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:1995;4878-4884.
34. Sharpe A. H. Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice. Curr. Opin. Immunol. 7:1995;389-395.
35. Shiratori T., Miyatake S., Ohno H., Nakaseko C., Isono K., Bonifacino J. S., Saito T. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP- 2. Immunity. 6:1997;583-589.
36. Tivol E. A., Borriello F., Schweitzer A. N., Lynch W. P., Bluestone J. A., Sharpe A. H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:1995;541-547.
37. Tivol E. A., Schweitzer A. N., Sharpe A. H. Costimulation and autoimmunity. Curr. Opin. Immunol. 8:1996;822-830.
38. Tomer Y., Barbesino G., Keddache M., Greenberg D. A., Davies T. F. Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J. Clin. Endocrinol. Metab. 82:1997;1645-1648.
39. Wu Y., Guo Y., Huang A., Zheng P., Liu Y. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J. Exp. Med. 185:1997;1327-1335.
40. Yanagawa T., Hidaka Y., Guimaraes V., Soliman M., DeGroot L. J. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab. 80:1995;41-45.
41. Zhang Y., Allison J. P. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. Proc. Natl. Acad. Sci. USA. 94:1997;9273-9278.
42. Zheng P., Wu Y., Guo Y., Lee C., Liu Y. B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge. Proc. Natl. Acad. Sci. USA. 95:1998;6284-6289.